Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Pravesh Kumar Bundhun"'
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background The American College of Obstetricians and Gynecologists (ACOG) makes certain recommendations including the annual influenza vaccination of pregnant and pre-pregnant women during influenza (flu) season with an inactivated influenza
Externí odkaz:
https://doaj.org/article/e211abee310240d6b7f09060cc74c2a8
Autor:
Pravesh Kumar Bundhun, Girish Janoo, Akash Bhurtu, Abhishek Rishikesh Teeluck, Mohammad Zafooruddin Sani Soogund, Manish Pursun, Feng Huang
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Nowadays, the total number of couples visiting an infertility clinic is on the rise. Tobacco smoking is considered one of the major factors leading to male infertility. In this study, we aimed to systematically investigate the imp
Externí odkaz:
https://doaj.org/article/c7fa13098ffe4e3e91939aac2a2e045e
Publikováno v:
Diabetes Therapy. 14:387-399
Type 2 diabetes mellitus (T2DM) is often associated with macrovascular complications including cardiovascular diseases (CVDs), resulting in acute coronary syndrome (ACS). Newer potent antiplatelet agents have recently been approved for use in clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc6c9edeffca1add45a17c633a80737
https://doi.org/10.1007/s13300-022-01354-5
https://doi.org/10.1007/s13300-022-01354-5
Publikováno v:
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background We aimed to systematically compare arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus (SLE), primary anti-phospholipid syndrome (PAPS) and secondary anti-phospholipid syndrome
Externí odkaz:
https://doaj.org/article/9150a464db5b4fa5a89066215a003a81
Autor:
Pravesh Kumar Bundhun, Feng Huang
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Due to limitations associated with clopidogrel following percutaneous coronary intervention (PCI), other newer oral anti-platelet agents are being studied. We aimed to systematically carry out a direct comparison of outcomes obser
Externí odkaz:
https://doaj.org/article/c08e5896c4c04da186a82aa3f3a6cace
Publikováno v:
BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background Prasugrel and Ticagrelor are emerging antiplatelet drugs that might have the potential to replace currently used antiplatelet agents. Previous analyses comparing prasugrel with ticagrelor mainly focused on an indirect comparison w
Externí odkaz:
https://doaj.org/article/65405a5522b948a0ad6b13f610597fc6
Publikováno v:
BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-10 (2017)
Abstract Background Vildagliptin and pioglitazone/rosiglitazone are emerging Oral Hypoglycemic Agents (OHAs) which are used to treat patients suffering from Type 2 Diabetes Mellitus (T2DM). In this analysis, we aimed to systematically compare the adv
Externí odkaz:
https://doaj.org/article/c8445c5b4b7a4304be3ba8cf21055cd6
Autor:
Pravesh Kumar Bundhun, Akash Bhurtu, Manish Pursun, Mohammad Zafooruddin Sani Soogund, Abhishek Rishikesh Teeluck, Wei-Qiang Huang
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-18 (2017)
Abstract Several previously published trials comparing Zotarolimus Eluting Stents (ZES) with Sirolimus Eluting Stents (SES), Paclitaxel Eluting Stents (PES) or Everolimus Eluting Stents (EES) at a follow up period of 1 year, were continually being fo
Externí odkaz:
https://doaj.org/article/eb4f01da6094445ea7f0f662ef0f90f9
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background We aimed to systematically compare Major Adverse Cardiac Events (MACEs) and mortality following Percutaneous Coronary Intervention (PCI) in patients with and without Chronic Obstructive Pulmonary Diseases (COPD) through a meta-ana
Externí odkaz:
https://doaj.org/article/d1e6fc0f418e4f60b673ac85036d0f97
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background Scientific reports have shown Type 2 Diabetes Mellitus (T2DM) to be independently associated with adverse outcomes following Percutaneous Coronary Intervention (PCI). However, gender difference has also often been a controversial
Externí odkaz:
https://doaj.org/article/d0319f1a2fdd42328edcea89b722b7cc